Royalty rate due to regulatory approvals
Bristol-Myers Squibb·Geographic·2 segments
Breakdown
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 |
|---|---|---|---|---|---|---|---|---|
| Restof World Except Japan South Koreaand Taiwan | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| North America | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| Total | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
All segment values are derived from annual filings.
Segments
North AmericaView metric
Restof World Except Japan South Koreaand TaiwanView metric